The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs.
| Image |  |
|---|---|
| Description | scientific article published in January 2003 |
| Author/s |
author: Martin Hewison Chris Bunce |
| Publication date | January 1, 2003 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |